Subscribe to news

Press Center

29.04.2016
PJSC HSCI, today announced its audited consolidated results for the full year 2015 in accordance with the International Financial Reporting Standards (IFRS)
28.04.2016
The Human Stem Cells Institute, today announced the decision of the Company’s Board of Directors on convocation of the Annual General Shareholders’ Meeting upon the results of FY2015
01.04.2016
PJSC HSCI, today announced its audited unconsolidated results for 2015 in accordance with the Russian Accounting Standards (RAS)
11.01.2016
The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, today announced that its innovative drug Neovasculgen® was included in the List of Vital and Essential Drugs (VED) for 2016 in Russia (according to the government directive № 2724-р of 26 December 2015).
06.11.2015
The Human Stem Cells Institute, today announced its unaudited unconsolidated results for the first nine months of 2015 in accordance with the Russian Accounting Standards (RAS)
16.09.2015
PJSC HSCI, today announced that its researchers presented results of their work at the 2015 TERMIS World Congress which took place in Boston on September 8-11, 2015.
03.09.2015
The Human Stem Cells Institute, today announced its unaudited consolidated interim results for the first half of 2015 in accordance to International Financial Reporting Standards (IFRS)
06.08.2015
PJSC HSCI, today announced its unaudited unconsolidated results for the first half of 2015 in accordance with the Russian Accounting Standards (RAS)
18.06.2015
The Human Stem Cells Institute today announced the results of the Annual General Shareholders’ Meeting (AGM) held on June 18, 2015 in Moscow.
19.05.2015
The Human Stem Cells Institute, today announced its unaudited unconsolidated results for the first quarter of 2015 in accordance with the Russian Accounting Standards (RAS)